Landmark stroke clinical trials DAWN and DEFUSE 3 helped validate the benefits of endovascular thrombectomy (EVT) procedure in acute ischemic stroke...

ApTOLL, a neuroprotective agent, has shown promising results in the APRIL 1b/2a trial and reduced death and disability when used alongside standard...

Rapid ICH 3.0 and Rapid Hyperdensity represent the best-in-class hemorrhagic solutions supporting clinicians managing intracranial hemorrhage (both...

Based on current evidence, treatment with intravenous alteplase is recommended for patients with DWI-FLAIR mismatch or perfusion mismatch on CT or...